MedTrace Logo

Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer

NCT02514408 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-01-02

No results posted yet for this study

Summary

This pilot clinical trial studies the impact of radical cystectomy (surgery) on the expulsion (release) of circulating tumor cells into the blood stream in patients with bladder cancer. Significant surgery such as radical cystectomy may cause the expulsion of tumor cells. Studying the release of tumor cells into the circulation may help doctors understand the impact that radical cystectomy has on tumor metastasis and/or tumor recurrence.

Conditions

  • Stage II Bladder Urothelial Carcinoma

Interventions

PROCEDURE

Catheter Management

Insertion of venous catheter under ultrasound guidance

OTHER

Cytology Specimen Collection Procedure

Collection of blood samples

OTHER

Laboratory Biomarker Analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Inderbir Gill, MD · University of Southern California

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2019-02-05
Completion
2019-03-05

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02514408 on ClinicalTrials.gov